Interview Dr Rafael Rosell


Rafael Rosell Image
Rafael Rosell, MD PhD

Dr Rosell is also Chief Medical Officer and President of the Dr Rosell Oncology Institute, University Hospitals Dexeus, Teknon, General de Catalunya & Sagrat Cor, Quirónsalud Group. Additionally, he is Director of the Cancer Biology and Precision Medicine Program, Catalan Institute of Oncology, Germans Trias & Pujol Hospital (Barcelona), and Founder & Chief Scientific Officer of Pangaea Oncology SA. He is furthermore Professor of Medicine at the Autonomous University of Barcelona.

Dr Rosell is a member of the ETOP Foundation Council, serves on the ESMO Annual Congress Scientifc Sub-Committee (non-small-cell lung cancer) and Editorial Board member of several medical journals. He is the Founder and Director of International Relations and Projects, Spanish Lung Cancer Group, and served as President from its inception in 1991 until 2014. He is a driving force behind current Spanish medical oncology research. He has over 600 articles published in peer-reviewed journals and has given hundreds of invited lectures at international medical conferences. In 2013, he was recognized as one of the highest authorities in lung cancer in Europe by The Lancet.

Javier Rivela Image
Javier Rivela, MBA, CFA
General Secretary
  • > 6 years in the field of biotechnology and 12 years in investment banking
  • Currently CEO/Founder, Pangaea Oncology SA
    • Small SME in the field of patient care and targeted therapies


  • Co-Head of ING’s European Small & Mid Cap Research Team, Madrid
    • Engaged I various biotech IPO/secondary placement transactions
  • Equity research positions:
    • Banco Santander, Madrid             
    • Redwood Securities, California USA
  • Credit risk analysis at Chevron-Texaco, California USA